PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Vinorelbine
Presentation Product Chemical substance Chapter Items dispensed
Navelbine 10mg/1ml concentrate for inf vials
0801040R0BBAAAA
Navelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Navelbine 20mg capsules
0801040R0BBACAC
Navelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Navelbine 30mg capsules
0801040R0BBADAD
Navelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Navelbine 50mg/5ml concentrate for inf vials
0801040R0BBABAB
Navelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Navelbine 80mg capsules
0801040R0BBAEAE
Navelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 10mg/1ml solution for infusion vials
0801040R0AAAAAA
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 20mg capsules
0801040R0AAACAC
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 30mg capsules
0801040R0AAADAD
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 50mg/5ml solution for infusion vials
0801040R0AAABAB
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 80mg capsules
0801040R0AAAEAE
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.